
Campbell's (CPB) is set to report Q4 earnings on Sept. 3, with analysts forecasting a decline in EPS to $0.57 from $0.63 year-over-year, despite an expected revenue increase to $2.33 billion from $2.29 billion. This mixed financial outlook follows a recent 1.5% share price dip and a trend of multiple analysts, including Morgan Stanley, Piper Sandler, JP Morgan, and Jefferies, maintaining neutral/hold ratings while consistently cutting price targets, signaling a cautious sentiment among institutional researchers ahead of the release.
Campbell's (CPB) faces a mixed outlook ahead of its fourth-quarter earnings report, with consensus estimates projecting a 1.7% year-over-year revenue increase to $2.33 billion but a 9.5% decline in earnings per share to $0.57 from $0.63. This divergence suggests potential margin compression, a key concern reflected in recent market and analyst activity. The stock's 1.5% decline to $31.46 precedes the announcement, indicating investor caution. This sentiment is amplified by a consistent pattern of downward price target revisions from several high-accuracy analysts. Notably, Piper Sandler downgraded the stock from Overweight to Neutral with a price target cut to $34, while Morgan Stanley, JP Morgan, and Jefferies all maintained neutral-equivalent ratings but also lowered their respective price targets. These actions, coming after a better-than-expected third quarter, signal that institutional researchers are tempering their near-term expectations and see limited upside, focusing instead on the anticipated profitability challenges in the upcoming report.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment